REG - Kanabo Group PLC - Contract Extension With Major UK Retailer

KanaboAnnouncement

14/11/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231114:nRSN2855Ta&default-theme=true

RNS Number : 2855T  Kanabo Group PLC  14 November 2023

 

14 November 2023

 

Kanabo Group Plc

("Kanabo", the "Group" or the "Company")

 

Contract Extension With Major UK Retailer

 

Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health
services and specialist medicines, including medicinal cannabis, is pleased to
announce that it has extended an existing contract with a leading United
Kingdom ("UK") retail business, a provider of health and beauty retail and
e-pharmacy services.

 

The GP Service - acquired by Kanabo in 2022 - originally partnered with the
retailer in 2019. The contract extension will see Kanabo, through its
integrated online telehealth platform The GP Service, continue to provide the
retailer with video consultation and prescription services, which patients can
access remotely and then collect through the Group's network of over 4,000 UK
pharmacies for a further 12 months.

 

This contract extension will enable Kanabo to continue to offer its online
consultation services to an expanded patient base, affording patients faster
and easier access to medical professionals.

 

 

Avihu Tamir, Chief Executive Officer of Kanabo, commented:

 

"I am delighted that we have secured an extension of this prestigious contract
for Kanabo. The continuation of our relationship with this retailer will help
us strengthen our position as a key player in digital health services and also
provide accessible care to patients. We look forward to continuing to work
with them over the next 12 months, and to enabling greater access to medical
professionals and healthcare services for customers."

 

 

Enquiries:

 Kanabo Group plc                                                 via Vigo Consulting

 Avihu Tamir, Chief Executive Officer                             +44 (0)20 7390 0230

 Assaf Vardimon, Chief Financial Officer

 Ian Mattioli, Non-Executive Chair of the Board

 Peterhouse Capital Limited (Financial Adviser and Broker)        +44 (0)20 7469 0930

 Eran Zucker / Lucy Williams / Charles Goodfellow

 Vigo Consulting (Financial Public Relations/Investor Relations)   +44 (0)20 7390 0230

 Jeremy Garcia / Fiona Hetherington / Verity Snow

 kanabo@vigoconsulting.com (mailto:kanabo@vigoconsulting.com)

 

About Kanabo Group plc

Kanabo Group plc (LSE:KNB) is a digital health company committed to
transforming patient care through its innovative technology platform and
specialised treatment offerings. Since its inception in 2017, Kanabo has been
focused on researching, developing, and commercialising regulated medicinal
cannabis-derived formulations and therapeutic inhalation devices.

 

Kanabo's NHS-approved online telehealth platform, The GP Service, provides
patients with video consultations, online prescriptions, and primary care
services. Leveraging its telehealth capabilities, in February 2023, Kanabo
launched Treat It - an online clinic focused on chronic pain management
providing patients with secondary care.

 

With its two complementary business divisions, Kanabo has established itself
as an end-to-end digital health provider, offering telehealth consultations,
prescriptions, alongside the delivery of tailored treatments.

 

The Company's partially owned subsidiary, Kanabo Agritec Ltd, is a cultivation
consultancy supporting cannabis businesses in developing new farms through
infrastructural, research, and product guidance. These farms deliver
high-quality raw materials for Kanabo's formulas and product line.

 

At Kanabo Group Plc, we are dedicated to providing patients with the highest
quality medical treatments and more accessible healthcare experiences.

Visit (http://www.kanabogroup.com/) www.kanabogroup.com
(http://www.kanabogroup.com/) for more information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CNTDZMMMVFZGFZM